VIAV Form 144: Khaykin-related sales reported
VIAV filed a Form 144 reporting proposed sales of Common stock by Oleg Khaykin and related irrevocable trusts.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VIAV filed a Form 144 reporting proposed sales of Common stock by Oleg Khaykin and related irrevocable trusts.
The excerpt lists multiple reported transactions: 123,333 shares on 05/07/2026 for $6,342,855.86; 104,552 shares on 05/05/2026 for $5,709,919.29; and additional trust sales on 05/06/2026, 05/05/2026, 02/10/2026, 02/09/2026 with amounts shown for each line item. The filing also references performance share awards dated 09/26/2023 and 03/01/2025.
Insights
Routine Form 144 notices list proposed resale transactions by insider-related trusts and individuals.
Form 144 is a regulatory notice that must be filed to effect certain restricted or control-person sales. The excerpt shows specific share counts and gross proceeds tied to each reported sale date, which are factual disclosures of proposed transactions.
Review subject-to conditions in full filings and broker statements for settlement mechanics; subsequent SEC filings may report the actual settlement results.
Key Figures
Key Terms
Form 144 regulatory
Irrevocable Trust legal
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who reported the sales in the VIAV Form 144?
What other sale examples are included in the filing excerpt?
What is the filing form type and its regulatory purpose?
AI-generated analysis. How Rhea-AI works. Not financial advice.